IMC Chicago
AXSM icon

IMC Chicago’s Axsome Therapeutics AXSM Stock Holding History

IMC Chicago’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Buy
15,000
+3,600
+32% +$781K ﹤0.01% 2427
2026
Q1 		$1.93M Sell
11,400
-12,200
-52% -$2.11M ﹤0.01% 2614
2025
Q4 		$4.31M Buy
23,600
+10,500
+80% +$1.47M ﹤0.01% 1847
2025
Q3 		$1.59M Buy
+13,100
New +$1.48M ﹤0.01% 2398

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IMC Chicago's AXSM Position: Q2 2026 in Review

IMC Chicago increased its Axsome Therapeutics (AXSM) stake by 30% in Q2 2026, buying an estimated $507K and bringing the position to 10,187 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

IMC Chicago first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • IMC Chicago held 10,187 shares of Axsome Therapeutics worth $2.49M as of Q2 2026.
  • IMC Chicago bought 2,340 Axsome Therapeutics shares in Q2 2026, an estimated $507K.
  • Axsome Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2795 holding.
  • IMC Chicago first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.